Amgen Drug Approval Faces Data Allegations
Over 100 groups are calling on Congress to reject rushed approvals for data centers. The coalition cites concerns regarding irreversible harm and a lack of public oversight for Big Tech operations.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Citing 'Irreversible Harm,' 100+ Groups Urge Congress to Reject Rushed Data Center Approvals“Congress must not let Big Tech block oversight and hide data centers’ real harms from the public”
Hacker News
“FDA alleges 'manipulated' data supported approval of Amgen's autoimmune drug.”
Hacker News
“approval of Amgen's autoimmune drug.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade